M&A Deal Summary

AIkido Pharma Acquires DatChat

On March 13, 2018, AIkido Pharma acquired information technology company DatChat

Acquisition Highlights
  • This is AIkido Pharma’s 1st transaction in the Information Technology sector.
  • This is AIkido Pharma’s 2nd transaction in the United States.
  • This is AIkido Pharma’s 1st transaction in New Jersey.

M&A Deal Summary

Date 2018-03-13
Target DatChat
Sector Information Technology
Buyer(s) AIkido Pharma
Deal Type Add-on Acquisition

Target

DatChat

New Brunswick, New Jersey, United States
DatChat, Inc. is a personal privacy platform, focused on encrypted communication, internet security and digital rights management. DatChat was founded in 2014 and is based in New Brunswick, New Jersey.

Search 201,429 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

AIkido Pharma

New York, New York, United States

Category Company
Founded 1967
Sector Information Technology
Employees4
Revenue 1M USD (2017)
DESCRIPTION

AIkido Pharma is a scientific research company offers a diversified commercialization platform for protected technologies. AIkido Pharma founded was incorporated in 1967 and is based in New York, New York.


DEAL STATS #
Overall 2 of 4
Sector (Information Technology) 1 of 1
Type (Add-on Acquisition) 2 of 2
State (New Jersey) 1 of 1
Country (United States) 2 of 4
Year (2018) 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2017-06-20 Hoth Therapeutics

United States

Hoth Therapeutics is a development stage biopharmaceutical company focused on the development of therapeutics for patients suffering from atopic dermatitis, such as eczema.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2018-10-11 CBM Biopharma

United States

CBM Biopharma LLC is a privately held pharmaceutical company with a team of drug development scientists provides numerous cancer treatment, including acute myeloid leukemia (AML), Acute Lymphoblastic Leukemia (ALL) and pancreatic cancer.

Buy -